Cadrenal Therapeutics, Inc. (CVKD): Cash & Equivalents
$4.01M
As of 2025-12-31
$2.39M
As of 2026-06-30
n/m
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.01M | -60.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $10.02M | +19.2% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $8.40M | n/m | 2024-03-11, Balance as of period end |
| 2022-12-31 | $32.6K | n/a | 2024-03-11, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | $4.01M | -60.0% |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | $4.09M | -57.1% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $2.07M | -54.6% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.14M | +198.9% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $5.14M | +11.3% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.51M | -9.0% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $3.01M | n/m |
| CDT Equity Inc. (CDT) | 2025-12-31 | $1.51M | +172.4% |
| Ernexa Therapeutics Inc. (ERNA) | 2024-12-31 | $1.73M | -77.2% |
Compare CVKD, PULM, AZTR, PTPI side by side · Screen every company in Pharmaceutical Preparations ↗